Universal Health Services Inc (UHS) Narx-foyda multiplikatori

Tizimli ishga qabul qilish va ichki xodimlarni o'qitish Universal Health Services (UHS) klinikalaridagi ishchi kuchi yetishmovchiligini yumshatadi. AI monitoringi va raqamli protokollarning joriy etilishi davolash boshqaruvini modernizatsiya qiladi. Kompaniyaning P/E koeffitsiyenti dinamikasi bozor kutganlarini tasdiqlaydi, bunda 6.70 darajasi joriy qiymatni ifodalaydi. Biznes barqarorligi AQSh va Buyuk Britaniyadagi shoshilinch yordam shifoxonalari va xulq-atvor sog'lig'i markazlari o'rtasidagi diversifikatsiyaga tayanadi.

UHS: Universal Health Services Corp Narx-foyda koeffitsiyenti 04.07.2022 - 11.11.2026

Universal Health Services Inc (UHS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:

Birja narxi Universal Health Services Corp|UHS - Maqsadli narxlar grafigi

- bozor kapitallashuvi tafsilotlari:

Bozor kapitallashuvi Universal Health Services, Inc.|UHS - Kompaniyani butunlay sotib olishdagi haqiqiy narx

- emitentning balans qiymati statistikasi:

Aksiyaning balans narxi Universal Health Services|UHS - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati uhsinc.com|UHS - Kompaniyaning jami aktivlari

- qarz majburiyatlari va likvidlik statistikasi:

Qarzning xususiy kapitalga nisbati Universal Health Services|UHS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Universal Health Services Corp|UHS - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Universal Health Services, Inc.|UHS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Universal Health Services|Oraliq qoplash koeffitsiyenti uhsinc.com

- foyda va qiymat multiplikatorlari haqida ma'lumot:

UHS - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi Universal Health Services|UHS - P/E multiplikatori|Forvard P/E multiplikatori Universal Health Services Corp|UHS - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Universal Health Services, Inc.|UHS - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Universal Health Services|UHS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi uhsinc.com|UHS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Universal Health Services

Kompaniyaning umumiy tahlili:uhsinc.com

P/E koeffitsiyenti bitta aksiyaning bozor qiymatini sof foydaga nisbatan belgilaydi va investorni kelajakdagi daromadlar uchun qo'shimcha to'lov qilishga tayyorligini o'lchaydi. Ushbu koeffitsiyent emitentning fundamental barqarorligini baholash imkonini beradi va xarajatlar ortishi fonida marja siqilishi xavfini aniqlaydi. GURU.Markets platformasida Universal Health Services (UHS) kompaniyasining hozirda 6.70 deb qayd etilgan P/E darajasini tahlil qilish orqali bozor kutganlarini baholash mumkin. Bu Universal Health Services (UHS) uchun juda muhimdir, chunki foyda davlat moliyalashtirishi va tibbiyot xodimlari yetishmovchiligi tufayli cheklangan.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati HCA Holdings HCA|Narxning foydaga nisbati Tenet Healthcare Corporation (THC)|Fresenius Medical Care AG - Narx-foyda multiplikatori|Solventum Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati EHC (Encompass)|DVA: Narx-foyda koeffitsiyenti|RDNT - P/E multiplikatori|Option Care Health, Inc. (OPCH) - Narxning foydaga nisbati|Narx-foyda multiplikatori SGRY|PINC (Premier Corp) - P/E multiplikatori|America's Best Contacts & Eyeglasses (EYE) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti PGNY (Progyny, Inc.)|Narxning foydaga nisbati ARDT (ardenthealth.com)|P/E multiplikatori SEM (Select Medical Holdings)|Astrana Health Inc (ASTH) - Kapitalizatsiyaning foydaga nisbati|MD - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati USPH (U.S. Physical Therapy)|The Pennant Group, Inc. (PNTG) - Narxning foydaga nisbati|ORGO - Biznesning o‘zini qoplash muddati|NUTX (Nutex Health) - P/E multiplikatori|P/E multiplikatori Auna S.A.|Narxning foydaga nisbati SBC Medical Corp (SBC)|Narxning foydaga nisbati EOLS (Evolus Corp)|Community Health Systems - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SKIN|MediWound, Ltd. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati BTMD (Biote)|JYNT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati DocGo, Inc (DCGO)|PIII (P3 Health Partners, Inc.) - P/E multiplikatori|P/E multiplikatori gaintherapeutics.com|Narxning foydaga nisbati EUDA Health Holdings Limited (EUDA)|Narxning foydaga nisbati BMGL (baselmedical.com)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CUPR (Cuprina Holdings Limited)|Concord Medical Services - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati AMS (ashs.com)|MRM (MEDIROM Healthcare Group) - Narx-foyda koeffitsiyenti|Avalon GloboCare Corp. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati DIH Holding US Inc.|Carmell Corp (XAGE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori NIVF|ATIP - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati CareMax CMAX|Kompaniya qiymatining sof foydaga nisbati KDLY|MODV: Narx-foyda koeffitsiyenti|NVOS: Narxning foydaga nisbati|SSY: P/E multiplikatori|BACK - Biznesning o‘zini qoplash muddati